Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
81,502,841
-
Shares change
-
+2,837,777
-
Total reported value, excl. options
-
$4,039,756,305
-
Value change
-
+$65,534,475
-
Put/Call ratio
-
1.79%
-
Number of buys
-
184
-
Number of sells
-
-155
-
Price
-
$49.57
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2018
421 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q4 2018.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81,502,841 shares
of 175,611,455 outstanding shares and own 46.41% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,800,949 shares), Vanguard Group Inc (6,072,744 shares), JPMORGAN CHASE & CO (5,340,899 shares), FMR LLC (5,197,235 shares), WELLINGTON MANAGEMENT GROUP LLP (4,068,122 shares), ALLIANCEBERNSTEIN L.P. (2,597,624 shares), BANK OF AMERICA CORP /DE/ (2,038,476 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,709,960 shares), ZEVENBERGEN CAPITAL INVESTMENTS LLC (1,699,990 shares), and JANUS HENDERSON GROUP PLC (1,597,121 shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.